Bionomics Statistics

Total Valuation

Bionomics has a market cap or net worth of $9.65 million. The enterprise value is $738,498.

Market Cap	9.65M
Enterprise Value	738,498

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Bionomics has 10.69 million shares outstanding. The number of shares has increased by 14.43% in one year.

Shares Outstanding	10.69M
Shares Change (YoY)	+14.43%
Shares Change (QoQ)	+1.23%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.11%
Float	n/a

Valuation Ratios

The trailing PE ratio is 0.03.

PE Ratio	0.03
Forward PE	n/a
PS Ratio	643.33
Forward PS	n/a
PB Ratio	0.50
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	49.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.05.

Current Ratio	3.81
Quick Ratio	3.47
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-978.98

Financial Efficiency

Return on equity (ROE) is -80.80% and return on invested capital (ROIC) is -0.74%.

Return on Equity (ROE)	-80.80%
Return on Assets (ROA)	-65.20%
Return on Capital (ROIC)	-0.74%
Revenue Per Employee	$1,875
Profits Per Employee	-$2.64M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Bionomics has paid $2,517 in taxes.

Income Tax	2,517
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.21% in the last 52 weeks. The beta is -0.08, so Bionomics's price volatility has been lower than the market average.

Beta (1Y)	-0.08
52-Week Price Change	-67.21%
50-Day Moving Average	0.99
200-Day Moving Average	1.57
Relative Strength Index (RSI)	38.42
Average Volume (30 Days)	96,241

Short Selling Information

The latest short interest is 118,160, so 1.10% of the outstanding shares have been sold short.

Short Interest	118,160
Short Previous Month	165,563
Short % of Shares Out	1.10%
Short % of Float	n/a
Short Ratio (days to cover)	3.13

Income Statement

In the last 12 months, Bionomics had revenue of $14,998 and -$21.09 million in losses.

Revenue	14,998
Gross Profit	14,776
Operating Income	-150,774
Pretax Income	-20.78M
Net Income	-21.09M
EBITDA	n/a
EBIT	-20.76M
Earnings Per Share (EPS)	$33.54

Full Income Statement

Balance Sheet

The company has $9.96 million in cash and $1.05 million in debt, giving a net cash position of $8.91 million or $0.83 per share.

Cash & Cash Equivalents	9.96M
Total Debt	1.05M
Net Cash	8.91M
Net Cash Per Share	$0.83
Equity / Book Value	19.46M
Book Value Per Share	1.82
Working Capital	8.33M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.85M
Capital Expenditures	n/a
Free Cash Flow	-17.85M
FCF Per Share	-$2.16

Full Cash Flow Statement

Margins

Gross margin is 98.52%, with operating and profit margins of -1,005.29% and -140,642.11%.

Gross Margin	98.52%
Operating Margin	-1,005.29%
Pretax Margin	-138,542.96%
Profit Margin	-140,642.11%
EBITDA Margin	n/a
EBIT Margin	-138,401.59%
FCF Margin	-119,048.72%

Dividends & Yields

Bionomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.43%
Shareholder Yield	-14.43%
Earnings Yield	-218.62%
FCF Yield	-185.05%

Analyst Forecast

The average price target for Bionomics is $9.00, which is 897.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	897.34%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bionomics has an Altman Z-Score of -9.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.24
Piotroski F-Score	2